Physicians with difficult patient scenarios regularly bring their questions to the AGA Community to seek advice from colleagues about therapy and disease management options, best practices, and diagnoses. Here’s a preview of a recent popular clinical discussion:
Vikrant Parihar, MD, wrote the following in “COVID-19 and UC”:
A 43-year-old man with an index presentation of distal colitis (Montreal E2) (Mayo endoscopic score 2-3) was discharged home on tapering doses of oral steroids. He was being worked up to commence anti-TNF likely initially as combo therapy. Fully vaccinated against COVID – had both doses of vaccine way back in May. Attended a match and looks to have got mild symptoms and on testing turned out to be COVID+. Rx himself by self-quarantine.
What would be the optimal strategy?
1. Stop steroids completely and immediately given the adverse signal in registry data?
2. When can anti-TNF’s be safely started?
3. How to manage him in the interim?
See how AGA members responded and join the discussion: https://community.gastro.org/posts/25172.
